Monthly Archives: May 2023

Community pharmacy contractors are not required to undertake a contractor-chosen or an NHS England determined clinical audit in 2023/24. This follows PSNC’s request to remove this clinical governance requirement for contractors in 2023/24. A clinical audit on anticoagulants is included in the Pharmacy Quality Scheme (PQS) 2023/24. If contractors choose to not participate in PQS, [...]

The post No mandatory clinical audits in 2023/34 appeared first on PSNC Website.

From May 30th we will be known as Community Pharmacy England, with new branding designed to be more impactful and authoritative, helping us to better represent community pharmacy. Alongside the name change we will be starting to implement a new engagement and communications strategy to open up a better dialogue with pharmacy owners (our members). This is [...]

The post PSNC to become Community Pharmacy England appeared first on PSNC Website.

PSNC and others have issued a statement on the wellbeing of the pharmacy workforce, recognising their shared endeavour to support pharmacy teams across all sectors to deliver patient care.  The Royal Pharmaceutical Society (RPS) and Pharmacist Support hosted a roundtable to discuss the impact of pharmacy workforce wellbeing on patient safety. PSNC Director of Contractor [...]

The post PSNC and others pledge support for wellbeing of pharmacy workforce  appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Micronised Progesterone (Utrogestan®) 100mg capsules. MSN/2023/052 Tier 2 – medium impact Date of issue 19th May 2023 There are intermittent supplies of micronised progesterone (Utrogestan®) 100mg capsules until late 2023, resulting in brief periods every month when this product will be [...]

The post Medicine Supply Notification: Micronised Progesterone (Utrogestan ® ) 100mg capsules appeared first on PSNC Website.

Update 01/09/23 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Utrogestan® 100mg capsules (SSP056) was due to expire 1 September 2023 but has been further extended to Friday 29 September 2023. Update 09/06/23 – The Department of Health and Social Care (DHSC) has [...]

The post Extension to Utrogestan® 100mg capsules SSP (SSP056) appeared first on Community Pharmacy England.